In vitro diagnostics and laboratory technology

Procurement of in vitro diagnostics

The WHO procurement service for in vitro diagnostics was established in 1990 to facilitate Member States' access to high quality HIV test kits at a reasonable cost. Over the years, the service has expanded to include diagnostics for HIV/AIDS, malaria, hepatitis B and hepatitis C, as well as basic laboratory consumables and equipment.

About the WHO procurement service

The Prequalification team - Diagnostics works together with the Contracting and Procurement Services team to ensure the availability of quality diagnostics at reduced costs. In 2007, the service achieved:

  • procurement of test kits for 45 Member States, the majority in low-income economies
  • expansion of the market for HIV and malaria rapid tests
  • procurement of 13 million test kits for priority diseases
  • substantial savings for member states
WebBuy catalogue

WebBuy, an electronic procurement system is available on the WHO intranet for easy, streamlined purchasing. Access to WebBuy is available for staff at WHO headquarters and regional and country offices.

Information for manufacturers

WHO procurement focuses on in vitro diagnostics for priority diseases such as HIV, malaria, hepatitis B and hepatitis C. In order for a diagnostic test kit to become eligible to tender for WHO procurement, it must first successfully pass through prequalification and meet specific procurement criteria. Tenders, by invitation only, occur on an annual basis.

For procurement questions

Contact: Contracting and Procurement Services (WHO/CPS) email:procurement@who.int

Procurement guidance for countries

Procurement information and statistics

EMERGENCY USE ASSESSMENT AND LISTING (EUAL) PROCEDURE


Request for Proposals

22 MARCH 2017

The Prequalification Team is publishing a request for proposals for consultancy services relating to - developing and maintaining the Quality Management Systems (QMS) and assuming the responsibility for on-going system maintenance and effectiveness of operations within the Prequalification Team.

The services required by the World Health Organization (WHO) are more fully described in the below attached Terms of Reference and Request for Proposals.

Proposals should be submitted to WHO in writing no later than 5 April 2017 at 17:00 hours Geneva time ("the closing date"), by email at the following address: mubangizid@who.int

ESSENTIAL MEDICINES AND HEALTH PRODUCTS


Contact us

Prequalification Team - Diagnostics
Regulation of Medicines and other Health Technologies
Department of Essential Medicines and Health Products
(HIS/EMP/RHT/PQT)
World Health Organization
20 Avenue Appia
1211, Geneva 27
Switzerland
diagnostics@who.int